Immunic, Inc. (IMUX)
NASDAQ: IMUX · Real-Time Price · USD
0.975
-0.045 (-4.41%)
At close: Jan 31, 2025, 4:00 PM
0.980
+0.005 (0.51%)
After-hours: Jan 31, 2025, 5:12 PM EST
Immunic Market Cap
Immunic has a market cap or net worth of $87.83 million as of January 31, 2025. Its market cap has increased by 60.86% in one year.
Market Cap
87.83M
Enterprise Value
29.66M
1-Year Change
60.86%
Ranking
Category
Stock Price
$0.98
Market Cap Chart
Since April 17, 2014, Immunic's market cap has decreased from $253.40M to $87.83M, a decrease of -65.34%. That is a compound annual growth rate of -9.35%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 31, 2025 | 87.80M | -2.55% |
| Dec 31, 2024 | 90.10M | 33.09% |
| Dec 29, 2023 | 67.70M | 23.09% |
| Dec 30, 2022 | 55.00M | -78.11% |
| Dec 31, 2021 | 251.20M | -20.71% |
| Dec 31, 2020 | 316.80M | 222.94% |
| Dec 31, 2019 | 98.10M | 1,141.77% |
| Dec 31, 2018 | 7.90M | -96.85% |
| Dec 29, 2017 | 251.10M | 80.13% |
| Dec 30, 2016 | 139.40M | -60.23% |
| Dec 31, 2015 | 350.50M | -41.04% |
| Dec 31, 2014 | 594.50M | 134.61% |
View and export this data all the way back to 2014.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 741.99B |
| UnitedHealth Group | 504.81B |
| Novo Nordisk | 374.46B |
| Johnson & Johnson | 366.99B |
| AbbVie | 330.86B |
| Merck & Co. | 251.80B |
| Thermo Fisher Scientific | 231.21B |
| Abbott Laboratories | 222.43B |